ARYX: Insider Transactions for ARYx Therapeutics, Inc. - Yahoo! Finance India

Insider Purchases - Last 6 Months
	Shares	Trans
Purchases	N/A	0
Sales	2,000,000	1
Net Shares Purchased (Sold)	(2,000,000)	1
Total Insider Shares Held	6.79M	N/A
% Net Shares Purchased (Sold)	(22.8%)	N/A

Net Institutional Purchases - Prior Qtr to Latest Qtr
	Shares
Net Shares Purchased (Sold)	1,286,260
% Change in Institutional Shares Held	10.1%

Data provided by Reuters

INSIDER & RULE 144 TRANSACTIONS REPORTED - LAST TWO YEARS

Date	Insider	Shares	Transaction	Value*
17-Aug-09	DRUZGALA PASCAL Officer	17,964	Disposition (Non Open Market)	N/A
22-May-09	ORBIMED ADVISORS LLC Beneficial Owner (10% or more)	2,000,000	Sale at $4 per share.	$8,000,000
14-Nov-08	GROWTH EQUITY OPPORTUNITIES FUND, LLC Beneficial Owner (10% or more)	4,469,274	Statement of Ownership	N/A
14-Nov-08	KERINS PATRICK J Beneficial Owner (10% or more)	4,469,274	Statement of Ownership	N/A
14-Nov-08	LINEHAN CHARLES M Beneficial Owner (10% or more)	4,469,274	Statement of Ownership	N/A
14-Nov-08	DRANT RYAN D Beneficial Owner (10% or more)	4,469,274	Statement of Ownership	N/A
14-Nov-08	BASKETT FOREST Beneficial Owner (10% or more)	4,469,274	Statement of Ownership	N/A
14-Nov-08	KOLLURI KRISHNA KITTU Beneficial Owner (10% or more)	4,469,274	Statement of Ownership	N/A
14-Nov-08	TRAINOR III EUGENE A Beneficial Owner (10% or more)	4,469,274	Statement of Ownership	N/A
14-Nov-08	ADELMAN ROBERT J Director	1,214,646	Purchase	N/A
14-Nov-08	SIMON NICHOLAS J III Director	1,787,710	Purchase at $2.20 per share.	$3,932,962
14-Nov-08	MPM BIOVENTURES III QP LP Beneficial Owner (10% or more)	1,787,710	Purchase at $2.20 per share.	$3,932,962
14-Nov-08	EVNIN LUKE Beneficial Owner (10% or more)	1,787,710	Purchase at $2.20 per share.	$3,932,962
14-Nov-08	ORBIMED ADVISORS LLC Beneficial Owner (10% or more)	1,214,646	Purchase	N/A
27-Oct-08	DRUZGALA PASCAL Officer	15,368	Disposition (Non Open Market)	N/A

Data provided by EDGAR Online

* = Where indicated, some values are estimates.
¹ = Potential proceeds estimated by the filer.
² = Estimated based on the average of multiple prices reported.
³ = Multiple dates reported. Most recent date shown.

All Major Holders - Insider Roster

Add to Portfolio Email to a Friend

ARYx Therapeutics, Inc. (ARYX)

MORE ON ARYX